Jason F. Wiggins
- Cancer Research top 0.5%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 2
- Molecular Biology top 2%
- Bacillus and Francisella bacterial research 7
- RNA Interference and Gene Delivery 5
- Biotechnology top 5%
- Cancer Research and Treatments 2
- Microbial Inactivation Methods 2
- Oncology top 10%
- Immunology top 10%
-
- Bacterial Genetics and Biotechnology 4
- Virus-based gene therapy research 2
Jason F. Wiggins
19 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 2.2k
- Molecular Biology 2.9k
- Biotechnology 172
- Oncology 406
- Immunology 231
Countries citing papers authored by Jason F. Wiggins
This map shows the geographic impact of Jason F. Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason F. Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason F. Wiggins more than expected).
Fields of papers citing papers by Jason F. Wiggins
This network shows the impact of papers produced by Jason F. Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason F. Wiggins. The network helps show where Jason F. Wiggins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jason F. Wiggins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2018 | 1 | |
| 3 | 2016 | 5 | |
| 4 | 2014 | 137 | |
| 5 | 2012 | 1 | |
| 6 | Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Micebreakdown → | 2011 | 525 |
| 7 | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44breakdown → | 2011 | 1136 |
| 8 | Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34breakdown → | 2010 | 532 |
| 9 | 2008 | 484 | |
| 10 | 2007 | 27 | |
| 11 | 2007 | 59 | |
| 12 | 2006 | 31 | |
| 13 | 2006 | 19 | |
| 14 | 2006 | 54 | |
| 15 | 2006 | 44 | |
| 16 | 2005 | 146 | |
| 17 | 2005 | 26 | |
| 18 | 2004 | 76 | |
| 19 | 1984 | 94 |
About Jason F. Wiggins
Jason F. Wiggins is a scholar working on Cancer Research, Biotechnology and Physiology, having authored 19 papers that have together received 3.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Bacillus and Francisella bacterial research (7 papers), RNA Interference and Gene Delivery (5 papers), Bacterial Genetics and Biotechnology (4 papers), Virus-based gene therapy research (2 papers), Cancer Research and Treatments (2 papers), Microbial Inactivation Methods (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (2.2k citations), Molecular Biology (2.9k citations) and Biotechnology (172 citations). Jason F. Wiggins has collaborated with scholars based in United States. Frequent co-authors include Andreas G. Bader, David Brown, Lubna Patrawala, Kevin Kelnar, Michael Omotola, Joanne B. Weidhaas, Frank J. Slack, Phong Trang, Stephen H. Leppla and Mahtab Moayeri. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.